Immediate Impact

1 by Nobel laureates 1 from Science/Nature 54 standout
Sub-graph 1 of 24

Citing Papers

Harnessing Nanomaterials for Cancer Sonodynamic Immunotherapy
2023 Standout
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study
2020 Standout
2 intermediate papers

Works of Olaf Koch being referenced

Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma
2003
Prognostic Value of Hemoglobin Concentrations in Patients with Advanced Head and Neck Cancer Treated with Combined Radio-Chemotherapy and Surgery
2000

Author Peers

Author Last Decade Papers Cites
Olaf Koch 200 147 104 149 34 457
Stephen I. Bulova 123 97 94 141 21 399
Joyce Murata‐Collins 97 135 130 172 31 475
Annunziata Manna 173 59 224 136 29 475
Scott Marshall 129 73 69 140 32 456
Anna Pawłowska 94 123 29 124 42 454
Frauke Bellos 98 137 65 251 21 423
Raffaella Stocchi 168 97 67 259 20 450
Peter Bojko 177 90 42 259 35 508
Bungo Saito 156 71 100 199 45 463
Byoung Kook Kim 133 68 92 187 43 405

All Works

Loading papers...

Rankless by CCL
2026